Indulekha clears second clinical trial, claims 2x efficacy over Redensyl rivals
Unilever-owned Ayurvedic brand Indulekha says its Bringha Hair Growth Serum delivered 11,000 new strands in 90 days, 74% A:T ratio improvement and 97% hair-fall reduction in its second clinical trial—positioning it against 3% Redensyl serums in India's crowded scalp-serum category.
Unilever-owned Ayurvedic haircare brand Indulekha announced completion of a second clinical trial for its Bringha Hair Growth Serum, claiming 11,000 new hair strands in 90 days and 2x efficacy versus 3% Redensyl-based competitors in India's crowded scalp serum category.